Status:
ENROLLING_BY_INVITATION
Project OASIS: Optimizing Approaches to Select Implementation Strategies
Lead Sponsor:
VA Office of Research and Development
Collaborating Sponsors:
VA Pittsburgh Healthcare System
VA Palo Alto Health Care System
Conditions:
Cirrhosis
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Barriers that prevent healthcare methods supported by science from being adopted in the real world have led to low-quality, inequitable medical care. Implementation science aims to bridge the evidence...
Detailed Description
Implementation science aims to improve the uptake of evidence-based health care practices (EBPs) by defining barriers that prevent their use, offering strategies to overcome these barriers, and develo...
Eligibility Criteria
Inclusion
- Veterans:
- Veterans with two outpatient or one inpatient codes for cirrhosis or its complications who had an encounter in the prior 18 months at a participating VA medical center
- VA clinicians:
- Physicians, advance practice providers, nurses, leadership, and staff engaged with selecting and applying implementation strategies to improve care at a participating VA medical center
Exclusion
- Veterans post-transplant or with active hepatocellular carcinoma
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
8020 Patients enrolled
Trial Details
Trial ID
NCT06061328
Start Date
February 1 2024
End Date
October 31 2027
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, United States, 15240